← All trials
NCT04498936
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 15, 2020
- Primary completion
- Oct 30, 2020
- Completion date
- Oct 30, 2020
- First posted
- Aug 5, 2020
- Last posted
- Nov 12, 2020
- Enrollment
- 240
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Assiut UniversityLead sponsor
- Assiut UniversityOverall official - principal investigator
- Assiut UniversityReponsible party - principal investigator
- Helwan UniversityCollaborator
- Helwan UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.